Jayamas Medica Industri Future Growth
Future criteria checks 1/6
Jayamas Medica Industri is forecast to grow earnings and revenue by 9.7% and 5.5% per annum respectively. EPS is expected to grow by 9.6% per annum. Return on equity is forecast to be 12.1% in 3 years.
Key information
9.7%
Earnings growth rate
9.6%
EPS growth rate
| Medical Equipment earnings growth | 22.5% |
| Revenue growth rate | 5.5% |
| Future return on equity | 12.1% |
| Analyst coverage | Low |
| Last updated | 31 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,045,000 | 347,000 | N/A | 514,000 | 1 |
| 12/31/2025 | 1,865,000 | 306,000 | N/A | 358,000 | 1 |
| 12/31/2024 | 1,774,000 | 273,000 | N/A | 571,000 | 1 |
| 9/30/2024 | 1,835,015 | 287,902 | 286,786 | 393,866 | N/A |
| 6/30/2024 | 1,805,296 | 292,696 | 283,441 | 410,472 | N/A |
| 3/31/2024 | 1,767,482 | 266,397 | 149,396 | 309,431 | N/A |
| 12/31/2023 | 1,736,990 | 259,360 | -22,087 | 134,354 | N/A |
| 9/30/2023 | 1,737,449 | 282,502 | -54,712 | 108,950 | N/A |
| 6/30/2023 | 1,736,966 | 271,834 | -92,719 | 45,683 | N/A |
| 3/31/2023 | 1,686,211 | 259,451 | -128,169 | -36,795 | N/A |
| 12/31/2022 | 1,739,054 | 285,782 | 17,247 | 92,617 | N/A |
| 3/31/2022 | 2,193,793 | 518,360 | 279,157 | 358,919 | N/A |
| 12/31/2021 | 2,226,573 | 562,692 | 422,324 | 505,108 | N/A |
| 12/31/2020 | 1,994,540 | 685,510 | 226,289 | 278,735 | N/A |
| 12/31/2019 | 1,228,049 | 226,208 | 160,224 | 174,718 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMED's forecast earnings growth (9.7% per year) is above the savings rate (6.8%).
Earnings vs Market: OMED's earnings (9.7% per year) are forecast to grow slower than the ID market (19% per year).
High Growth Earnings: OMED's earnings are forecast to grow, but not significantly.
Revenue vs Market: OMED's revenue (5.5% per year) is forecast to grow slower than the ID market (9.7% per year).
High Growth Revenue: OMED's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMED's Return on Equity is forecast to be low in 3 years time (12.1%).